UltraPlex
UltraPlex pioneering sustainable and cost-efficient liposome-based RNA therapeutics delivery.
Status:
Pre-business
SDGs:
Good health and well-being
Industry:
Life science and medical
Impact:
Quality of life
Origin:
Research to Business
School:
School of Science
Established:
2025
The UltraPlex project develops a next-generation liposome-based drug delivery system for RNA therapeutics that is sustainable, cost-efficient, and scalable for pharmaceutical applications. Traditional liposomal formulations face challenges such as high production costs, solvent dependency, material waste, and therapeutic molecule encapsulation inefficiency issues, limiting their commercial viability. UltraPlex addresses these challenges by integrating green chemistry, nanotechnology, and focused ultrasound principles to create an eco-friendly and efficient drug delivery platform.
Contact
Christopher Fogarty
Business Developer
Read more about innovation services
News from innovation ecosystem
Student exchange in Europe? Unite! can take you there
Aalto is a member of Unite!, a European university alliance that gives students the opportunity to internationalise their degrees both online and in-person. Join the webinar to find out more.
Take advantage of UniSport’s autumn campaign and explore the news
Autumn campaign and affordable membership for Aalto University students and staff!
Join the Unite!Energy Conference in Darmstadt
The third annual Unite!Energy Conference brings together early-career researchers and experts to exchange knowledge, explore the latest developments and innovations in sustainable energy, and discuss the role of gender-responsive STEM education.